297 related articles for article (PubMed ID: 6896838)
21. Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species.
Gibson SJ; Polak JM; Bloom SR; Sabate IM; Mulderry PM; Ghatei MA; McGregor GP; Morrison JF; Kelly JS; Evans RM
J Neurosci; 1984 Dec; 4(12):3101-11. PubMed ID: 6209366
[TBL] [Abstract][Full Text] [Related]
22. Localization of vasoactive intestinal peptide immunoreactivity in human foetus and newborn infant spinal cord.
Charnay Y; Chayvialle JA; Said SI; Dubois PM
Neuroscience; 1985 Jan; 14(1):195-205. PubMed ID: 3883230
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin-like immunoreactivity in the dorsal horn of the spinal cord of the rat: a light and electron microscopic study.
Conrath-Verrier M; Dietl M; Tramu G
Neuroscience; 1984 Nov; 13(3):871-85. PubMed ID: 6084830
[TBL] [Abstract][Full Text] [Related]
24. Release of calcitonin gene-related peptide (CGRP), substance P (SP), and vasoactive intestinal polypeptide (VIP) from rat spinal cord: modulation by alpha 2 agonists.
Takano M; Takano Y; Yaksh TL
Peptides; 1993; 14(2):371-8. PubMed ID: 7683402
[TBL] [Abstract][Full Text] [Related]
25. VIP terminals, axons, and neurons: distribution throughout the length of monkey and cat spinal cord.
LaMotte CC; de Lanerolle NC
J Comp Neurol; 1986 Jul; 249(1):133-45. PubMed ID: 3525616
[TBL] [Abstract][Full Text] [Related]
26. Cholecystokinin-like immunoreactivity in the dorsal horn of the rat spinal cord: an attempt to analyse contradictory results between immunocytochemistry and radioimmunoassay.
Zouaoui D; Benoliel JJ; Conrath M; Cesselin F
Neuropeptides; 1990 Dec; 17(4):177-85. PubMed ID: 2093150
[TBL] [Abstract][Full Text] [Related]
27. Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction.
Hang CH; Shi JX; Li JS; Wu W; Li WQ; Yin HX
World J Gastroenterol; 2004 Mar; 10(6):875-80. PubMed ID: 15040036
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.
Perry RH; Dockray GJ; Dimaline R; Perry EK; Blessed G; Tomlinson BE
J Neurol Sci; 1981 Sep; 51(3):465-72. PubMed ID: 6268760
[TBL] [Abstract][Full Text] [Related]
29. Vasoactive intestinal polypeptide (VIP)-containing neurons in the spinal cord of the rat and their projections.
Fuji K; Senba E; Ueda Y; Tohyama M
Neurosci Lett; 1983 May; 37(1):51-5. PubMed ID: 6308519
[TBL] [Abstract][Full Text] [Related]
30. Vasoactive intestinal polypeptide and substance P in primary afferent pathways to the sacral spinal cord of the cat.
Kawatani M; Erdman SL; de Groat WC
J Comp Neurol; 1985 Nov; 241(3):327-47. PubMed ID: 2418069
[TBL] [Abstract][Full Text] [Related]
31. Release of substance P from the cat spinal cord.
Go VL; Yaksh TL
J Physiol; 1987 Oct; 391():141-67. PubMed ID: 2451003
[TBL] [Abstract][Full Text] [Related]
32. Effects of peripheral axotomy on cholecystokinin neurotransmission in the rat spinal cord.
Antunes Bras JM; Laporte AM; Benoliel JJ; Bourgoin S; Mauborgne A; Hamon M; Cesselin F; Pohl M
J Neurochem; 1999 Feb; 72(2):858-67. PubMed ID: 9930763
[TBL] [Abstract][Full Text] [Related]
33. Vasoactive intestinal polypeptide (VIP) immunoreactivity in the ependymal cells of the rat spinal cord.
Chung K; Lee WT
Neurosci Lett; 1988 Dec; 95(1-3):1-6. PubMed ID: 3226599
[TBL] [Abstract][Full Text] [Related]
34. A VIP-containing system concentrated in the lumbosacral region of human spinal cord.
Anand P; Gibson SJ; McGregor GP; Blank MA; Ghatei MA; Bacarese-Hamilton AJ; Polak JM; Bloom SR
Nature; 1983 Sep 8-14; 305(5930):143-5. PubMed ID: 6193428
[TBL] [Abstract][Full Text] [Related]
35. Vasoactive intestinal polypeptide in visceral afferent pathways to the sacral spinal cord of the cat.
Kawatani M; Lowe IP; Nadelhaft I; Morgan C; De Groat WC
Neurosci Lett; 1983 Dec; 42(3):311-6. PubMed ID: 6664634
[TBL] [Abstract][Full Text] [Related]
36. Co-existence of vasoactive intestinal polypeptide (VIP)- and cholecystokinin (CCK)-like immunoreactivities in thalamocortical neuron in the ventrolateral nucleus of the rat.
Ogawa R; Itoh K; Kaneko T; Mizuno N
Brain Res; 1989 Jun; 490(1):152-6. PubMed ID: 2758323
[TBL] [Abstract][Full Text] [Related]
37. Vasoactive intestinal polypeptide identified in the thoracic dorsal root ganglia of the cat.
Kuo DC; Kawatani M; de Groat WC
Brain Res; 1985 Mar; 330(1):178-82. PubMed ID: 2580591
[TBL] [Abstract][Full Text] [Related]
38. GABA, acting at both GABAA and GABAB receptors, inhibits the release of cholecystokinin-like material from the rat spinal cord in vitro.
Benoliel JJ; Bourgoin S; Mauborgne A; Pohl M; Legrand JC; Hamon M; Cesselin F
Brain Res; 1992 Sep; 590(1-2):255-62. PubMed ID: 1330214
[TBL] [Abstract][Full Text] [Related]
39. A spinal mechanism of action is involved in the antinociception produced by the capsaicin analogue NE 19550 (olvanil).
Dickenson A; Hughes C; Rueff A; Dray A
Pain; 1990 Dec; 43(3):353-362. PubMed ID: 2293145
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical localization of seven different peptides in the human spinal cord.
Chung K; Briner RP; Carlton SM; Westlund KN
J Comp Neurol; 1989 Feb; 280(1):158-70. PubMed ID: 2563739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
